P210 Safety and effectiveness of lumacaftor-ivacaftor in cystic fibrosis patients with ppFEV1 ≤40% or ≥90%

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []